搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
The Austin Chronicle
5 小时
Why Austin Loves the Polar Bear Plunge
Cold plunge enthusiasts point to heart benefits as well. When plunged into frigid water, the body constricts blood flow to ...
verywellhealth
23 小时
Pulmonary Angiography on Lungs: What Radiographic Imaging Can Show
Pulmonary angiography, specifically the computed tomographic version, is the gold standard for diagnosing lung embolism.
Monthly Prescribing Reference
2 天
Symvess, a Novel Treatment for Vascular Trauma, Gets FDA Approval
The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.
2 天
Humacyte's Symvess Debut: A Milestone With Lingering Concerns (Rating Downgrade)
Humacyte stock has dropped 46% since July, mainly due to FDA review delays. Check out why I downgraded HUMA stock from "buy" ...
FierceBiotech
3 天
FDA approves Humacyte’s off-the-shelf artery implant for vascular trauma repair
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed ...
The Mirror US on MSN
4 天
Tank Dell suffers horrific injury at hands of own teammate leaving CJ Stroud in tears
Houston Texans wide receiver Tank Dell suffered a horrific knee injury after catching a touchdown pass from CJ Stroud with ...
5 天
Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday?
On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod ...
6 天
on MSN
When 'hearing' your heartbeat could be a sign of something sinister
Although many people hear this noise when lying on their side - it could be a warning sign of increased blood pressure or ...
6 天
Humacyte surges on FDA approval for Symvess vascular repair product
Humacyte (HUMA) stock climbs as FDA approves Symvess, its implantable vascular conduit for arterial injury. Read more here.
bovnews
6 天
A Biotech Breakthrough: Humacyte’s (HUMA) Game-Changing FDA Approval Sends Stock Soaring
As of Friday’s premarket trading session, Humacyte’s stock surged +33.52% to $4.62, reflecting investor optimism following this groundbreaking news. While the company’s stock has had a solid +21.83% ...
6 天
Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for ...
SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈